OverviewChartNewsTraderScreen

Soc. Generale Call 680 LLY 19.06..../  DE000SU55KS0  /

EUWAX
6/7/2024  9:49:18 AM Chg.+0.04 Bid10:00:44 PM Ask10:00:44 PM Underlying Strike price Expiration date Option type
2.52EUR +1.61% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 680.00 - 6/19/2026 Call
GlobeNewswire 6/6 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 6/5 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 6/4 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 6/3 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 6/3 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 5/30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 5/24 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 5/23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 5/23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 5/23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 5/21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 5/16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 5/16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 5/16 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 5/15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 5/13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 5/9 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 5/9 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO